lilly retatrutide Eli Lilly's tirzepatide showed positive results in late-stage trial as treatment for heart failure Lilly's Retatrutide: Toward the End

The study randomized 445 participants in a 1:1:1 ratio to receive either retatrutide 9 mg or 12 mg, or placebo

PlexusDx maps 14 distinct metabolic pathways and 49 peptides through the Precision Peptide Genetic Test, identifying which pathways are driving your weight gain and which therapeutic targets are most likely to work for you personally

: SURMOUNT-5 (NEJM, 2025) : SURPASS-4 (The Lancet, 2021) , SURMOUNT-1 3 (NEJM, 2024) , SURPASS (ADA, 2021) , (Diabetes Care, 2023) GLP-1 30

DPP-4 inhibitors increase glycemic control in patients with type 2 diabetes through multiple mechanisms

they are generally less commonly prescribed now due to newer, more convenient options

Some health and wellness programs offer one-time payments, while others provide recurring commissions for subscription-based services